RxDoctor Payments Data

Amanda Wickson

Physician Assistant · Keller, TXNPI 1710177464

Payments from drug & device makers

$4,170in general payments, 2019–2025

Across 188 payments — averaging $22.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$1K
  • AbbVie$356
  • Novo Nordisk$304
  • Bayer$277
  • Lilly USA, LLC$225
  • Boehringer Ingelheim$214
  • plus $1K from 25 others

What the payments were for

  • Consulting fees$1,20029%
  • Food & beverage$2,97071%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,170 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$59,920
JardianceEmpagliflozin21$22,656
Trijardy XrEmpaglifloz/Linaglip/Metformin12$12,475
Rosuvastatin Calcium55$1,007
Potassium Chloride15$862
Atorvastatin Calcium93$809
Hydroxyzine Hcl14$674
Venlafaxine Hcl ErVenlafaxine Hcl13$624
Levothyroxine Sodium64$599
Duloxetine Hcl29$574
Omeprazole23$573
Trazodone Hcl34$395
Escitalopram Oxalate17$383
Gabapentin22$364
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$353

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$304$59,92044 claims
Boehringer IngelheimJardiance, Trijardy Xr$214$35,13233 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Keller

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →